Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:02 PM UTC
| NCT Number | NCT07062965 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 102 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 6, 2026 (May 6, 2026) |
As of July 19, 2026: Clinical trial NCT07062965 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 102 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07062965 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 102 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07062965 was last updated May 6, 2026 (May 6, 2026). HelloStudys verifies this status automatically.